Cancer Stem Cell Metabolomic Profiling Service
Creative Biolabs offers a sophisticated analytical framework designed to map the intricate metabolic networks of Cancer Stem Cells (CSCs), a population frequently responsible for therapeutic resistance and late-stage recurrence. By focusing on the metabolic plasticity of these cells, their ability to shift between anaerobic glycolysis and oxidative phosphorylation (OXPHOS), our service provides actionable data that standard bulk tumor analysis cannot capture. We assist your project by delivering high-resolution datasets on intracellular metabolites and exosomal signaling molecules, which are essential for validating drug mechanisms or identifying subclinical biomarkers.
Introduction to CSC Metabolic Reprogramming
CSCs are defined by their extraordinary metabolic plasticity, a fundamental survival mechanism that allows them to thrive within the hostile, nutrient-deprived, and hypoxic conditions of the tumor niche. Recent high-impact research indicates that CSCs do not rely on a static energy program; instead, they dynamically oscillate between anaerobic glycolysis and OXPHOS to fuel self-renewal and drive metastatic dissemination. Furthermore, metabolic byproducts such as lactate act as potent signaling molecules that reprogram tumor-associated macrophages (TAMs), fostering an immunosuppressive environment that facilitates tumor escape. Creative Biolabs' profiling service captures this dynamic state with unparalleled resolution, providing the "chemical snapshot" necessary to disrupt the bioenergetic circuitry of the tumor-initiating core.
Comprehensive Solutions
At Creative Biolabs, we provide an end-to-end metabolomic ecosystem tailored specifically for the unique physiological requirements of tumor-initiating cells. Our offerings combine industry-leading sensitivity with biological context to transform raw data into therapeutic insight.
Targeted & Untargeted Metabolomic Discovery
We utilize ultra-high-performance liquid chromatography coupled with mass spectrometry (UHPLC-MS) to detect a broad spectrum of metabolites. Our untargeted approach allows for the unbiased discovery of novel markers, while targeted assays provide absolute quantification of critical energy intermediates like ATP, Lactate, and TCA cycle acids.
Stable Isotope-Assisted Flux Analysis
To move beyond static snapshots, we offer metabolic flux analysis (MFA). By tracking labeled substrates, we can determine the actual "flow" through the pentose phosphate pathway (PPP) or glutaminolysis, revealing how CSCs prioritize biosynthetic pathways under stress.
CSC-Specific Lipidomic Profiling
Given the importance of structural lipids in stemness maintenance, our platform characterizes complex lipid species, including sphingomyelins and gangliosides (e.g., GM3), which are frequently enriched in aggressive CSC subpopulations and their secreted vesicles.
Mitochondrial Bioenergetic Assessment
We integrate metabolomics with functional mitochondrial assays. This includes the measurement of mitochondrial mass, membrane potential, and PGC1α-mediated biogenesis, providing a complete picture of the OXPHOS dependency in quiescent CSCs.
Single-Cell & Spatial Metabolomic Integration
For highly heterogeneous tumors, we offer specialized protocols to correlate metabolic profiles with spatial location within the tumor niche, ensuring that the influence of hypoxia and nutrient gradients is fully accounted for.
Explore Our Full Range of Capabilities and Drive Your Innovation Forward — Inquire for a Detailed Service Brochure
Workflow
Our standardized yet flexible workflow is designed to maintain the metabolic integrity of rare cell populations while providing a high-resolution view of their bioenergetic landscape.
Publication
This review examines the metabolic profiles of CSCs and normal stem cells, highlighting key pathways in glycolysis, oxidative phosphorylation, and lipid and amino acid metabolism. It explores the unique metabolic plasticity of CSCs, their role in tumor progression and therapy resistance, and the therapeutic potential of targeting these pathways to develop more effective cancer treatments.
Fig.1 Therapeutic strategies targeting metabolic pathways in CSCs. 1
Why Choose Us?
Creative Biolabs leads in immuno-metabolic profiling, moving beyond identification to track how CSCs reshape the tumor microenvironment. We specialize in detecting subtle chemical signatures, such as glycerophosphocholine markers linked to aggressive melanoma, even in complex patient serum. By integrating high-resolution mass spectrometry with deep biological expertise, we map the secretion of metabolically active exosomes and lipids that drive therapeutic resistance. This precision-engineered approach transforms raw data into actionable insights for biomarker discovery and drug development, providing a distinct competitive edge in targeting the metabolic foundations of cancer recurrence.
Experience the Creative Biolabs Advantage and Accelerate Your Discovery — Get a Personalized Quote Today
FAQs
Can you isolate CSCs from small-volume patient biopsies?
Yes, our protocols are designed to maximize CSC recovery from limited samples for high-sensitivity HRMS.
How does your exosomal profiling improve biomarker discovery?
Exosomes carry a concentrated "metabolic message" from the CSC, offering signatures more specific than total serum metabolites.
What precautions are taken to prevent metabolite degradation?
All samples are processed using immediate quenching with liquid nitrogen or cold methanol.
Customer Review
-
Precision Redox Assessment
Using Creative Biolabs' CSC Profiling has significantly facilitated the quantification of GSH/GSSG ratios in CD133+ populations, revealing redox shifts previously masked by the tumor bulk. - Dr. Al*rt S -
Exosomal Cargo Discovery
The ability to profile CSC-derived exosomes provided a liquid biopsy candidate we hadn't considered. Their focus on structural lipids was a game-changer. - Sarah M*son
Related Services
EpCAM Assay Portfolio Service
Creative Biolabs targets EpCAM, a transmembrane glycoprotein regulating cell adhesion, junctions, and proliferation. We analyze its role in CSC maintenance and context-dependent EMT signaling to validate cancer immunotherapy targets.
Learn More →Quality Control for In Vivo Assays
Creative Biolabs delivers GLP-compliant preclinical testing, providing rigorous in vivo assay design for CAR/TCR-T therapies. We optimize dosing, routes, and sample size to ensure statistically significant biological effects.
Learn More →How to Contact Creative Biolabs
Creative Biolabs offers a specialized CSC metabolomic profiling service that uncovers the hidden metabolic drivers of tumor resilience and therapeutic failure. By combining high-resolution mass spectrometry with deep expertise in the CSC niche, we help you transition from bulk analysis to the precision targeting of the cells that drive cancer progression.
Reach out to us to find out how our customized solutions can move your research from the lab to the next critical milestone.
Reference
- Stouras, Ioannis, et al. "Metabolic profiles of cancer stem cells and normal stem cells and their therapeutic significance." Cells 12.23 (2023): 2686. Distributed under Open Access license CC BY 4.0, without modification. https://doi.org/10.3390/cells12232686
Download our brochure